Literature DB >> 9787186

Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation.

A B Manodori1, N M Matsui, J Y Chen, S H Embury.   

Abstract

The adherence of sickle erythrocytes to vascular endothelium has the capacity to initiate vasoocclusion. The known effects of thrombin on endothelial cell function and the increased activity of thrombin in sickle cell disease led us to examine the effect of thrombin on the adhesivity of cultured endothelial cells for sickle erythrocytes. In particular, we studied whether the effect of thrombin on interendothelial cell gap formation (ICGF) was involved in endothelial cell adhesivity for sickle erythrocytes. Those endothelial cell monolayers stimulated by thrombin to maximal levels of static sickle erythrocyte adherence also underwent striking cell contraction and enlargement of interendothelial cell gaps. Adhesivity also increased when gaps were induced with antilaminin antibodies or EDTA. Maximally adhesogenic thrombin conditions failed to increase adhesivity when gap formation was prevented by pretreatment of the monolayers with 8-bromo-cyclic adenosine monophosphate (bromo-cAMP) or glutaraldehyde, agents that respectively inhibit actin-myosin-dependent cell contraction or cross-link adjacent cells in the monolayer. The influence of these two agents on EDTA-enhanced adhesivity was linked to their ability to prevent gap formation. Glutaraldehyde prevented both increased adherence and gap formation; bromo-cAMP prevented neither. Interendothelial cell gap formation may contribute to vasoocclusion by facilitating sickle erythrocyte adherence. Copyright 1998 by The American Society of Hematology

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787186

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction.

Authors:  J E Brittain; K J Mlinar; C S Anderson; E P Orringer; L V Parise
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domain.

Authors:  Suhita Gayen Betal; B N Yamaja Setty
Journal:  Transl Res       Date:  2008-09-04       Impact factor: 7.012

Review 3.  Sickle red cell-endothelium interactions.

Authors:  Dhananjay K Kaul; Eileen Finnegan; Gilda A Barabino
Journal:  Microcirculation       Date:  2009-01       Impact factor: 2.628

4.  Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities.

Authors:  Viviana P Montecinos; Claudio H Morales; Thomas H Fischer; Sarah Burns; Ignacio F San Francisco; Alejandro S Godoy; Gary J Smith
Journal:  J Cell Mol Med       Date:  2015-03-04       Impact factor: 5.310

5.  An unusual cause of acute renal failure in sickle cell disease.

Authors:  Marie-Antoinette Rockx; Ian W Gibson; Martina Reslerova
Journal:  NDT Plus       Date:  2009-07-22

Review 6.  The Shape Shifting Story of Reticulocyte Maturation.

Authors:  Elina Ovchynnikova; Francesca Aglialoro; Marieke von Lindern; Emile van den Akker
Journal:  Front Physiol       Date:  2018-07-11       Impact factor: 4.566

7.  Antithrombin-III mitigates thrombin-mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow.

Authors:  William J Wulftange; Erdem Kucukal; Yuncheng Man; Ran An; Karamoja Monchamp; Charlotte D Sevrain; Himanshu R Dashora; Amma T Owusu-Ansah; Allison Bode; Anton Ilich; Jane A Little; Nigel S Key; Umut A Gurkan
Journal:  Br J Haematol       Date:  2022-07-13       Impact factor: 8.615

8.  Mycoplasma suis infection results endothelial cell damage and activation: new insight into the cell tropism and pathogenicity of hemotrophic mycoplasma.

Authors:  Albina Sokoli; Katrin Groebel; Katharina Hoelzle; Werner M Amselgruber; José M Mateos; Mårten K J Schneider; Urs Ziegler; Kathrin M Felder; Ludwig E Hoelzle
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.